US jury orders Johnson & Johnson to pay $8bn to man with gynaecomastia linked to risperidone
Johnson €7.3bn) in punitive damages to Nicholas Murray, 26, who developed gynaecomastia while taking the atypical antipsychotic drug risperidone.Risperidone (marketed in the US by Janssen as…
